Genetic Organization and Mode of Action of a Novel Bacteriocin, Bacteriocin 51: Determinant of VanA-Type Vancomycin-Resistant Enterococcus faecium

被引:23
|
作者
Yamashita, Hitoshi [1 ]
Tomita, Haruyoshi [1 ,2 ]
Inoue, Takako [1 ]
Ike, Yasuyoshi [1 ,2 ]
机构
[1] Gunma Univ, Dept Bacteriol, Grad Sch Med, Gunma 3718511, Japan
[2] Gunma Univ, Lab Bacterial Drug Resistance, Grad Sch Med, Gunma 3718511, Japan
关键词
STREPTOCOCCUS-FAECALIS; PHEROMONE RESPONSE; ESCHERICHIA-COLI; PEDIOCIN FAMILY; SEX-PHEROMONE; PLASMID PPD1; CLONING; SYSTEM; HEMOLYSIN; PAD1;
D O I
10.1128/AAC.01274-10
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Bacteriocin 51 (Bac 51) is encoded on the mobile plasmid pHY (6,037 bp), which was isolated from vancomycin-resistant Enterococcus faecium VRE38. Bacteriocin 51 is active against E. faecium, E. hirae, and E. durans. Sequence analysis of pHY showed that it encodes nine open reading frames (ORFs) from ORF1 to ORF9 (in that order). Genetic analysis suggested that ORF1 and ORF2, which were designated bacA and bacB, respectively, are the bacteriocin and immunity genes. bacA encodes a 144-amino-acid protein. The deduced BacA protein has a typical signal sequence at its amino terminus, and a potential signal peptidase-processing site corresponding to the V-E-A sequence is located between the 37th and 39th amino acids. The predicted mature BacA protein consists of 105 amino acids. A potential promoter sequence was identified upstream of the start codon. bacB encodes a 55-amino-acid protein. No obvious promoter or terminator sequence was identified between bacA and bacB. Northern blot analysis of bacA and bacB with a bacA RNA probe produced a transcript of approximately 700 nucleotides, which corresponded to the combined nucleotide sizes of bacA and bacB, indicating that transcription was initiated from the promoter upstream of bacA, continued through bacB, and was terminated at the terminator downstream of bacB. The transcription start site was determined to be the T nucleotide located 6 nucleotides downstream from the -10 promoter sequence. These results indicate that bacA and bacB constitute an operon and that bacA is the bacteriocin structural gene while bacB is the immunity gene. The purified C-terminally His tagged BacA protein of Bac 51 showed bacteriostatic activity against the indicator strain. The purified C-terminally His tagged BacA protein of Bac 32 (whose mature BacA protein has 54 amino acids) and the culture filtrates of the Bac 31- and Bac 43-producing E. faecalis strain FA2-2 showed bactericidal activity. Bac 31 and Bac 43 are pore-forming bacteriocins, unlike the newly characterized bacteriocin Bac 51.
引用
收藏
页码:4352 / 4360
页数:9
相关论文
共 50 条
  • [21] Clinical implications of vancomycin-resistant Enterococcus faecium (VRE) with VanD phenotype and vanA genotype
    Song, Jae-Hoon
    Ko, Kwan Soo
    Suh, Ji Yoeun
    Oh, Won Sup
    Kang, Cheol-In
    Chung, Doo Ryeon
    Peck, Kyong Ran
    Lee, Nam Yong
    Lee, Wee Gyo
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (04) : 838 - 844
  • [22] VanD-type vancomycin-resistant Enterococcus faecium and Enterococcus faecalis
    Depardieu, F
    Kolbert, M
    Pruul, H
    Bell, J
    Courvalin, P
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (10) : 3892 - 3904
  • [23] Outbreak of vancomycin-resistant Enterococcus faecium containing both vanA and vanB gene clusters
    Dende, C.
    Ballard, S. A.
    Grabsch, E. A.
    Gao, W.
    Grayson, M. L.
    JOURNAL OF HOSPITAL INFECTION, 2009, 71 (04) : 379 - 381
  • [24] Emergence of vanA vancomycin-resistant Enterococcus faecium in a hospital in Porto Alegre, South Brazil
    Resende, Mariah
    Caierao, Juliana
    Prates, Juliana Gil
    Narvaez, Gabriel Azambuja
    Gomes Dias, Cicero Armidio
    d'Azevedo, Pedro Alves
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2014, 8 (02): : 160 - 167
  • [25] First characterization of a cluster of vanA-type glycopeptide-resistant Enterococcus faecium, Colombia
    Panesso, D
    Ospina, S
    Robledo, J
    Vela, MC
    Peña, J
    Hernández, O
    Reyes, J
    Arias, CA
    EMERGING INFECTIOUS DISEASES, 2002, 8 (09) : 961 - 965
  • [26] SHIN-2 exerts potent activity against VanA-type vancomycin-resistant Enterococcus faecium in vitro by stabilizing the active site loop of serine hydroxymethyltransferase
    Hayashi, Hironori
    Saijo, Erika
    Hirata, Kazushige
    Murakami, Shumei
    Okuda, Haruka
    Kodama, Eiichi N.
    Hasegawa, Kazuya
    Murayama, Kazutaka
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2024, 761
  • [27] A novel bacteriocin from Enterococcus faecalis 478 exhibits a potent activity against vancomycin-resistant enterococci
    Phumisantiphong, Uraporn
    Siripanichgon, Kanokrat
    Reamtong, Onrapak
    Diraphat, Pornphan
    PLOS ONE, 2017, 12 (10):
  • [28] Vancomycin-Resistant Enterococcus faecium in Tunisia: Emergence of Novel Clones
    Dziri, Raoudha
    El Kara, Feriel
    Barguellil, Farouk
    Ouzari, Hadda-Imen
    El Asli, Mohamed Selim
    Klibi, Naouel
    MICROBIAL DRUG RESISTANCE, 2019, 25 (04) : 469 - 474
  • [29] Genetic characterization of a VanG-type vancomycin-resistant Enterococcus faecium clinical isolate
    Sassi, Mohamed
    Guerin, Francois
    Lesec, Leonie
    Isnard, Christophe
    Fines-Guyon, Marguerite
    Cattoir, Vincent
    Giard, Jean-Christophe
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (04) : 852 - 855
  • [30] Emergence and dissemination of a highly vancomycin-resistant vanA strain of Enterococcus faecium at a large teaching hospital
    Pegues, DA
    Pegues, CF
    Hibberd, PL
    Ford, DS
    Hooper, DC
    JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (06) : 1565 - 1570